24-Hour Blood Pressure Control by Once-daily Administration of Losartan Assessed by Ambulatory Blood Pressure Monitoring
Li Yi
Abstract
Li Yi
Abstract
OBJECTIVE: To assess 24h ambulatory blood pressure lowerings and tolerability after weeks of therapy with losartan 50-100mg once daily. METHOD: After 1-week wash-out and 2-weeks placebo run-in, patients with seated diastolic blood pressure (SeDBP) 95-115mmHg and ambulatory diastolic blood pressure ≥ 85 mmHg were investigated by openlabel method with losartan 50mg treatment for 4 weeks, followed by dose titration to 100mg once-daily for another 4 weeks in those patients with SeDBP≥90mmHg. Ambulatory blood pressure monitoring (ABPM) was performed over 24-hour period after placebo run-in and at the end of weeks. RESULTS:Mean reductions from baseline in 24h, day -time (6:00-22:00), night-time (22:00-6:00) were (11.0 ?9.5/6.8 ?5.8),(11.5 ?10.8/7.0 ?6.2),(10.2 ?9.5/6.6 ? 7.0) mmHg. Trough: peak ratios were 75.5% for DBP and 74.5% for SBP. The frequency of adverse events was very low, and no cough happened. CONCLUSION: losartan 50- 100mg given once daily appears to be a well-tolerated, safe,and effective antihypertensive treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To assess 24h ambulatory blood pressure lowerings and tolerability after weeks of therapy with losartan 50-100mg once daily. METHOD: After 1-week wash-out and 2-weeks placebo run-in, patients with seated diastolic blood pressure (SeDBP) 95-115mmHg and ambulatory diastolic blood pressure ≥ 85 mmHg were investigated by openlabel method with losartan 50mg treatment for 4 weeks, followed by dose titration to 100mg once-daily for another 4 weeks in those patients with SeDBP≥90mmHg. Ambulatory blood pressure monitoring (ABPM) was performed over 24-hour period after placebo run-in and at the end of weeks. RESULTS:Mean reductions from baseline in 24h, day -time (6:00-22:00), night-time (22:00-6:00) were (11.0 ?9.5/6.8 ?5.8),(11.5 ?10.8/7.0 ?6.2),(10.2 ?9.5/6.6 ? 7.0) mmHg. Trough: peak ratios were 75.5% for DBP and 74.5% for SBP. The frequency of adverse events was very low, and no cough happened. CONCLUSION: losartan 50- 100mg given once daily appears to be a well-tolerated, safe,and effective antihypertensive treatment.
Key concepts: Medicine, Ambulatory blood pressure, Blood pressure, Tolerability, Losartan, Placebo, Ambulatory, Anesthesia